# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Shares of Eli Lilly And Company (NYSE: LLY) are moving higher on Wednesday. Here's what you need to know.
The Federal Trade Commission is preparing to sue the largest three pharmacy-benefit managers over their tactics for negotiating...
A study shows that only one in four U.S. patients prescribed Novo Nordisk's weight-loss drugs Wegovy or Ozempic remain on t...
https://www.dailymail.co.uk/health/article-13620101/ozempic-quitting-patients-weight-loss-effects.html?ns_mchannel=rss&ns_c...
Eli Lilly's acquisition of Morphic highlights strategic expansion in Immunology, targeting α4β7 for ulcerative colitis and ...
The CNN Money Fear and Greed index slightly decreased, remaining in Neutral zone. US stocks mixed, with S&P 500 at record h...